Deletion of CD44 promotes adipogenesis by regulating PPARγ and cell cycle-related pathways
Journal of Endocrinology · 2024
DOI: 10.1530/joe-24-0079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology, 2024. Verfasst von Xiong Weng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, Scotland, UK. Hauptthemen laut MEDLINE: 3T3-L1 Cells, Adipocytes, Adipogenesis, Cell Cycle. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.
Abstract (Originalsprache)
CD44, a cell surface adhesion receptor and stem cell biomarker, is recently implicated in chronic metabolic diseases. Ablation of CD44 ameliorates adipose tissue inflammation and insulin resistance in obesity. Here, we investigated cell type-specific CD44 expression in human and mouse adipose tissue and further studied how CD44 in preadipocytes regulates adipocyte function. Using Crispr Cas9-mdediated gene deletion and lentivirus-mediated gene re-expression, we discovered that deletion of CD44 promotes adipocyte differentiation and adipogenesis, whereas re-expression of CD44 abolishes this effect and decreases insulin responsiveness and adiponectin secretion in 3T3-L1 cells. Mechanistically, CD44 does so via suppressing Pparg expression. Using quantitative proteomics analysis, we further discovered that cell cycle-regulated pathways were mostly decreased by deletion of CD44. Indeed, re-expression of CD44 moderately restored expression of proteins involved in all phases of the cell cycle. These data were further supported by increased preadipocyte proliferation rates in CD44-deficient cells and re-expression of CD44 diminished this effect. Our data suggest that CD44 plays a crucial role in regulating adipogenesis and adipocyte function possibly through regulating PPARγ and cell cycle-related pathways. This study provides evidence for the first time that CD44 expressed in preadipocytes plays key roles in regulating adipocyte function outside immune cells where CD44 is primarily expressed. Therefore, targeting CD44 in (pre)adipocytes may provide therapeutic potential to treat obesity-associated metabolic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, Scotland, UK.
- Gene Expression and Regulation, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
- MRC Protein Phosphorylation Unit, School of Life Sciences, Dundee, Scotland, UK.
- Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
- Science for Life Laboratory, Department of Biomedical and Clinical Sciences (BKV), Linköping University, Linköping, Sweden.
ORCID-Profile: Li Kang
Förderung
- British Heart Foundation
Zitieren
APA
Weng, X., Jiang, H., Walker, D. J., Zhou, H., Lin, Wang, J., & Kang, L. (2024). Deletion of CD44 promotes adipogenesis by regulating PPARγ and cell cycle-related pathways. Journal of Endocrinology. https://doi.org/10.1530/joe-24-0079
Vancouver
Weng X, Jiang H, Walker DJ, Zhou H, Lin, Wang J, et al. Deletion of CD44 promotes adipogenesis by regulating PPARγ and cell cycle-related pathways. Journal of Endocrinology. 2024. doi:10.1530/joe-24-0079
BibTeX
@article{Weng2024,
author = {Weng, Xiong and Jiang, Hao and Walker, David J and Zhou, Houjiang and Lin, De and Wang, Jing and Kang, Li},
title = {Deletion of CD44 promotes adipogenesis by regulating PPARγ and cell cycle-related pathways},
journal = {Journal of Endocrinology},
year = {2024},
doi = {10.1530/joe-24-0079}
}
EUVIMED